Many resolutions fail not because they are unrealistic, but because they are launched under conditions of high internal ...
We look forward to the Sequire Investor Summit and the opportunity to meet with investors and update them on our novel targeted drug delivery platform as well as our lead product candidate APTN-101 ...
Some people are immune to dementia, even if their brain is deteriorating. Cognitive reserve is the secret boost that builds ...
They’ve been doing some early tests, and the results seem promising, especially when it comes to safety and how it might help manage weight. It’s still early days, but it’s definitely something to ...
The MarketWatch News Department was not involved in the creation of this content. Portland, Maine, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Most people believe dementia is a life sentence. Dr. Clint Steele ...
Portland, Maine, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Most people believe dementia is a life sentence. Dr. Clint Steele once believed that, too, until a moment in his practice changed everything. Today, ...
Taylor Snowden does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
The brain goes through five distinct stages between birth and death, a new study shows. Scientists identified the average ages—9, 32, 66 and 83—when the pattern of connections inside our brains shift.
The human brain has 86 billion neurons connected by roughly 100 trillion synapses, making it one of the most complex objects in the known universe. Each year neuroscientists make fascinating, ...
If you need another reason to visit the gym this winter, a new study of almost 1,200 healthy, middle-aged men and women found that those with more muscle mass tended to have younger brains than those ...
Portland, Maine, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Most people believe dementia is a life sentence. Dr. Clint Steele once believed that, too, until a moment in his practice changed everything. Today, ...
Radiopharm Theranostics Ltd.’s radiotracer RAD-101 met the primary endpoint in 92% of patients in the phase IIb imaging trial in brain metastases, according to interim results. To date, 11 of the 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results